These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18612428)

  • 1. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents.
    Yamaza T; Miura Y; Bi Y; Liu Y; Akiyama K; Sonoyama W; Patel V; Gutkind S; Young M; Gronthos S; Le A; Wang CY; Chen W; Shi S
    PLoS One; 2008 Jul; 3(7):e2615. PubMed ID: 18612428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of miRNA‑181a on FasL expression in bone marrow mesenchymal stem cells and its effect on CD4+T lymphocyte apoptosis in estrogen deficiency‑induced osteoporosis.
    Shao B; Fu X; Yu Y; Yang D
    Mol Med Rep; 2018 Jul; 18(1):920-930. PubMed ID: 29845202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
    Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
    Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.
    Liu Y; Wang L; Liu S; Liu D; Chen C; Xu X; Chen X; Shi S
    J Dent Res; 2014 Nov; 93(11):1124-32. PubMed ID: 25252877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse mandible contains distinctive mesenchymal stem cells.
    Yamaza T; Ren G; Akiyama K; Chen C; Shi Y; Shi S
    J Dent Res; 2011 Mar; 90(3):317-24. PubMed ID: 21076121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression.
    Chen C; Akiyama K; Yamaza T; You YO; Xu X; Li B; Zhao Y; Shi S
    EMBO Mol Med; 2014 Mar; 6(3):322-34. PubMed ID: 24401839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice.
    Lv YJ; Yang Y; Sui BD; Hu CH; Zhao P; Liao L; Chen J; Zhang LQ; Yang TT; Zhang SF; Jin Y
    Theranostics; 2018; 8(9):2387-2406. PubMed ID: 29721087
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance.
    Shao B; Liao L; Yu Y; Shuai Y; Su X; Jing H; Yang D; Jin Y
    FASEB J; 2015 Sep; 29(9):3935-44. PubMed ID: 26062603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
    Elabd C; Basillais A; Beaupied H; Breuil V; Wagner N; Scheideler M; Zaragosi LE; Massiéra F; Lemichez E; Trajanoski Z; Carle G; Euller-Ziegler L; Ailhaud G; Benhamou CL; Dani C; Amri EZ
    Stem Cells; 2008 Sep; 26(9):2399-407. PubMed ID: 18583541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats.
    Saito A; Nagaishi K; Iba K; Mizue Y; Chikenji T; Otani M; Nakano M; Oyama K; Yamashita T; Fujimiya M
    Sci Rep; 2018 Jan; 8(1):1161. PubMed ID: 29348535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin up-regulates bone marrow mesenchymal stem cells osteogenic action but suppresses their mediated osteoclastogenesis via MT
    Zhou Y; Wang C; Si J; Wang B; Zhang D; Ding D; Zhang J; Wang H
    Br J Pharmacol; 2020 May; 177(9):2106-2122. PubMed ID: 31900938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
    Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
    Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in viability and mineralization of osteoporotic bone marrow mesenchymal stem cell through combined application of photobiomodulation therapy and oxytocin.
    Fallahnezhad S; Jajarmi V; Shahnavaz S; Amini A; Ghoreishi SK; Kazemi M; Chien S; Bayat M
    Lasers Med Sci; 2020 Apr; 35(3):557-566. PubMed ID: 31399862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis.
    Akiyama K; Chen C; Wang D; Xu X; Qu C; Yamaza T; Cai T; Chen W; Sun L; Shi S
    Cell Stem Cell; 2012 May; 10(5):544-55. PubMed ID: 22542159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α.
    Liu Y; Wang L; Kikuiri T; Akiyama K; Chen C; Xu X; Yang R; Chen W; Wang S; Shi S
    Nat Med; 2011 Nov; 17(12):1594-601. PubMed ID: 22101767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery.
    Sui BD; Chen J; Zhang XY; He T; Zhao P; Zheng CX; Li M; Hu CH; Jin Y
    Exp Mol Med; 2018 Dec; 50(12):1-14. PubMed ID: 30559383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
    Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
    EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.